Avid Bioservices, Inc. has a 1 year low of $11.34 and a 1 year high of $21.05.

Source: https://www.etfdailynews.com/2023/07/12/avid-bioservices-inc-nasdaqcdmo-cfo-daniel-r-hart-sells-1269-shares-of-stock/

Craig Hallum reduced their price objective on shares of Avid Bioservices from $30.00 to $25.00 in a report on Wednesday, December 7th.

Source: https://www.etfdailynews.com/2023/01/28/comerica-bank-decreases-position-in-avid-bioservices-inc-nasdaqcdmo/

In other Avid Bioservices news, Director sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, December 2nd.

Source: https://www.etfdailynews.com/2023/01/28/avid-bioservices-inc-nasdaqcdmo-shares-acquired-by-allspring-global-investments-holdings-llc/

KeyCorp dropped their price objective on Avid Bioservices from $20.00 to $14.00 and set an “overweight” rating on the stock in a report on Friday, December 8th.

Source: https://www.americanbankingnews.com/2023/12/17/avid-bioservices-inc-nasdaqcdmo-shares-bought-by-alberta-investment-management-corp.html

Macquarie Group Ltd. raised its stake in Avid Bioservices by 0.5% during the second quarter.

Source: https://www.etfdailynews.com/2023/07/12/avid-bioservices-inc-nasdaqcdmo-ceo-nicholas-stewart-green-sells-7530-shares/

MetLife Investment Management LLC raised its holdings in Avid Bioservices by 50.1% in the 1st quarter.

Source: https://www.etfdailynews.com/2023/08/02/insider-selling-avid-bioservices-inc-nasdaqcdmo-ceo-sells-19519-shares-of-stock/